MAP3K8 and cancer: Consistent with this novel TPL2 function in p53 activation, several human cancers display reduced expression of TPL2 [4, 6] and recently published genetic evidence in the mouse suggests that this kinase operates in epithelial cells as suppressor of malignant transformation [6, 7].